Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (936) Tyzeka (telbivudine), Idenix Pharma,
...Newly Approved Drug Therapies (936) Tyzeka (telbivudine), Idenix Pharma, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Tyzeka (telbivudine) Company: Idenix Pharma Approval Status: Approved October 2006 Treatment Area: hepatitis B virus General Information ...
View Page

2.  Study Posting (5031) Trial #155118, Hepatitis B, Various Cities, TX
...is conducting this study to determine additional safety and dosing information for the study drug telbivudine for chronic hepatitis B participants who are of Black/Caribbean/African American or Hispanic/Latino ethnicity and between the ages of 16 and 70 years old. Telbivudine has been approved for sale in the United States by the U.S. Food and ...
View Page

3.  Study Posting (5031) Trial #155117, Hepatitis B, Various Cities, NY
...is conducting this study to determine additional safety and dosing information for the study drug telbivudine for chronic hepatitis B participants who are of Black/Caribbean/African American or Hispanic/Latino ethnicity and between the ages of 16 and 70 years old. Telbivudine has been approved for sale in the United States by the U.S. Food and ...
View Page

4.  Study Posting (5031) Trial #157828, Hepatitis B, Various Cities, IL
...is conducting this study to determine additional safety and dosing information for the study drug telbivudine for chronic hepatitis B participants who are of Black/Caribbean/African American or Hispanic/Latino ethnicity and between the ages of 16 and 70 years old. Telbivudine has been approved for sale in the United States by the U.S. Food and ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (777), Hepatitis B
...2006 Idenix and Novartis issued additional positive interim results of a phase III trial of telbivudine , for the treatment of chronic hepatitis B (CHB) infections, at the International Liver Congress in ...
...majority of whom were HBeAg-positive (n=290/332). Subjects were to receive treatment with telbivudine or the approved drug lamivudine through 2 years. November 21, 2005 Valeant announced interim results ...
View Page

6.  Study Posting (77) Trial #111015, Hepatitis, Manhasset, NY
...Have previously taken nucleoside or nucleotide analogue antiviral drugs (for example, adefovir, entecavir, famciclovir, tenoforvir, telbivudine, clevudine or emtracitabine) • Have been treated with interferon or other immuno-stimulators in the last ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (79), Hepatitis
...and the University of Hong Kong reported positive results from a phase IIb trial investigating telbivudine ( L-deoxythymidine or LdT ), a selective nucleoside for the treatment of hepatitis B virus (HBV). Results showed that telbivudine achieved significantly better suppression of HBV compared to lamivudine monotherapy, the current standard of care ...
View Page

8.  CenterWatch: New Medical Therapies in Disease Category (554), Clostridium Difficile-Associated Diarrhea
...and the University of Hong Kong reported positive results from a phase IIb trial investigating telbivudine ( L-deoxythymidine or LdT ), a selective nucleoside for the treatment of hepatitis B virus (HBV). Results showed that telbivudine achieved significantly better suppression of HBV compared to lamivudine monotherapy, the current standard of care ...
View Page

9.  CenterWatch: Immunology/Infectious Diseases Approved Drug Therapies
...For the prevention of gastroenteritis associated with rotavirus infections in infants, Approved February 2006 Tyzeka (telbivudine) ; Idenix Pharma; For the treatment of hepatitis B virus, Approved October 2006 Veregen (kunecatechins) ; Medigene ...
View Page

10.  CenterWatch: List of Newly Approved Drug Thearapies
...For the prevention of gastroenteritis associated with rotavirus infections in infants, Approved February 2006 Tyzeka (telbivudine) ; Idenix Pharma; For the treatment of hepatitis B virus, Approved October 2006 Veregen (kunecatechins) ; Medigene ...
View Page